Medtronic MDT

NYSE · Electromedical & Electrotherapeutic Apparatus · $128.9B
$100.61−0.11%Nov 19 close · Databento
Every report since 2022 →

Data provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.

2 stories have a settled next close so far (2 on the Wire). The record starts speaking at three.

The numbers

fiscal 2026, as filed with the SEC · 66-metric EOD snapshot via Databento
Market cap$128.9B
EV / True FCF30.4x
Revenue$36.4B +8.4%
True FCF (ex-SBC)$5.0B +4.6%
Rule of 4023.3%
ROIC7.1%
True FCF Yield3.9%
EPS, diluted$3.73 +3.3%
Modern Valuation (EOD)
Market Cap$128.9B
Enterprise Value$150.9B
EV / True FCF30.37
EV / FCF27.81
EV / Gross Profit—
EV / EBIT23.33
EV / Sales4.15
P / E (GAAP)26854020.32
P / FCF23.76
P / Oper. CF17.59
P / Book2.57
Owner & Cash Yields
True FCF Yield3.9%
FCF Yield4.2%
Owner Earn. Yield0.5%
Earnings Yield0.0%
Shareholder Yield+3.3%
Buyback Yield0.8%
Dividend Yield2.82%
Dividend / sh$2.84
Payout Ratio75796709%
FCF / sh$4.24
EPS (diluted)$3.73
Compounder & Returns
Rule of 4023.3%
ROIC7.1%
Cash ROIC (CROIC)7.5%
GP / Assets—
ROE0.0%
ROA0.0%
Gross Margin—
Oper. Margin17.8%
Net Margin0.0%
FCF Margin14.9%
True FCF Margin13.7%
Quality & Dilution
Cash Conversion113018121%
Accrual Ratio−7.9%
SBC % of FCF8.4%
SBC % of Rev1.3%
Reinvest. Rate26%
Sales Growth Y/Y+8.4%
Sales 3Y CAGR+5.2%
EPS Growth Y/Y+3.3%
FCF Growth Y/Y+4.6%
FCF 3Y CAGR+5.8%
Share Change Y/Y−0.1%
Balance Sheet & Scale
Revenue (FY)$36.4B
Gross Profit (FY)—
Oper. Income (FY)$6.5B
GAAP Net Income$4,801
True FCF (ex-SBC)$5.0B
Cash & Equiv$1.9B
Total Debt$23.9B
Net Cash (Debt)$-22.0B
Net Cash % MCap−17.0%
Debt / FCF (yrs)4.4y
Current Ratio2.131.28B sh
Price & Technicals (EOD)
Perf Week−0.38%
Perf Month+8.15%
Perf Quarter+7.78%
Perf Half Y+28.74%
Perf YTD+28.49%
SMA 20 Dist+0.67%$99.94
SMA 50 Dist+6.52%$94.45
SMA 100 Dist+10.62%$90.95
Window High−4.14%$104.96
Window Low+36.42%$73.75
RSI (14) · Vol56.030%v
Income Distribution & Cash Flow ConversionHow every dollar of MDT revenue flows through cost of goods, operating expenses, taxes, GAAP net income, and dilution-adjusted free cash flow
REVENUE · 100%$36.4BGROSS PROFIT · 65.0%$23.6BCOST OF REV · 35.0%$12.7BOPER. INCOME · 17.8%$6.5BOPEX · 47.2%$17.2B · SG&A $11.8BNET INCOME · 0.0%$4,801TAX & OTHER · 17.8%$6.5B
Where Every $100 of Revenue Goes (FY2026)
Cost of Revenue (COGS)$12.7B ($35.0 / $100)
SG&A & Other OpEx$17.2B ($47.2 / $100)
Tax & Non-Operating$6.5B ($17.8 / $100)
Net Profit Kept$4,801 ($0.0 / $100)
Earnings Quality: GAAP Profit → True Owner Cash (FY2026)
GAAP Net Income$4,801 (0.0% margin)
Operating Cash Flow (OCF)$7.3B(20.2% of rev)
Less: Capital Expenditures−$1.9B(5.2% of rev)
Standard Free Cash Flow (FCF)$5.4B(14.9% margin)
Less: Stock-Based Comp (SBC)−$457.0M(8.4% of FCF)
True FCF (Owner Cash ex-SBC)$5.0B(13.7% of rev)

Operating leverage — margins

GrossOperatingNet
0%40%80%18%0%FY22FY23FY24FY25FY26
Unlocked SEC EDGAR Accounting Statements (USD)All 3 statements · Common-size (% of Revenue / Assets) · YoY growth · Tap any core row to explain
Line Item (USD)FY2022FY2023FY2024FY2025FY2026YoY Δ4Y CAGRTrend
Income Statement
Cost of Revenue (COGS)$10.1B$10.7B$11.2B$11.6B$12.7B+9.4%+5.8%
Selling, General & Admin (SG&A)$10.3B$10.4B$10.7B$10.8B$11.8B+8.6%+3.4%
Interest Expense$553.0M$636.0M$719.0M$729.0M$715.0M−1.9%+6.6%
Income Tax Expense$456.0M$1.6B$1.1B$936.0M$1.3B+38.8%+29.9%
Diluted Shares1.35B1.33B1.33B1.29B1.29B−0.1%−1.2%
Balance Sheet
Cash & Equivalents$3.7B$1.5B$1.3B$2.2B$1.9B−12.1%−14.9%
Inventory$4.6B$5.3B$5.2B$5.5B$6.0B+8.7%+6.6%
Total Current Assets$23.1B$21.7B$21.9B$23.8B$24.8B+4.1%+1.8%
Total Assets$91.0B$90.9B$90.0B$91.7B$93.0B+1.5%+0.6%
Total Current Liabilities$12.4B$9.1B$10.8B$12.9B$11.7B−9.5%−1.5%
Total Debt (Short + Long Term)$25.9B$22.2B$23.2B$25.0B$23.9B−4.3%−1.9%
Total Liabilities$38.3B$39.3B$39.6B$43.4B$43.0B−1.1%+2.9%
Stockholders' Equity$52.7B$51.7B$50.4B$48.3B$50.1B+3.8%−1.3%
Net Cash / (Net Debt)$-22.2B$-20.6B$-21.9B$-22.8B$-22.0B+3.6%—
Invested Capital$74.9B$72.3B$72.4B$71.1B$72.1B+1.4%−1.0%
Cash Flow & Capital Allocation
Depreciation & Amortization (D&A)$2.7B$2.7B$2.6B$2.9B$3.0B+3.4%+2.2%
Stock-Based Compensation (SBC)$359.0M$355.0M$393.0M$429.0M$457.0M+6.5%+6.2%
Capital Expenditures (CapEx)$1.4B$1.5B$1.6B$1.9B$1.9B+2.4%+8.6%
True FCF (ex-SBC Owner Cash)$5.6B$4.2B$4.8B$4.8B$5.0B+4.5%−3.0%
Share Repurchases (Buybacks)$2.5B$645.0M$2.1B$3.2B$1.0B−68.0%−20.1%
Dividends Paid$3.4B$3.6B$3.7B$3.6B$3.6B+1.4%+1.8%

Fundamentals, income distribution and multi-year statements from SEC EDGAR filings (public domain). Valuation multiples, performance and technicals computed from Databento 1D EOD closes. For information only, not investment advice.

On the Wire

what MDT did at the next close after each story
The Wire at 7 AM ET, free. Top stories with a bull and a bear case on each, every morning. No account needed.